Navigation Links
Patients Say Costs Determining Factor in Their Treatment Decisions
Date:6/10/2009

WASHINGTON, June 10 /PRNewswire-USNewswire/ -- Seventy-three percent of insured patients receiving assistance from Patient Access Network (PAN) Foundation reported that health care costs are influencing their medication and treatment decisions more this year than last. Nearly half of these said that cost is having a "very big" or "big" impact on whether they seek treatment or fill prescriptions.

The results were part of a 2009 patient survey to determine the effects of the economy, the impact of PAN assistance on patients' lives and their satisfaction with PAN services. PAN helps insured individuals make copayments for medications for 21 specific diseases, including certain cancers and a number of chronic illnesses.

"Our patients do have health insurance; many have Medicare, and yet they still can't meet all the out-of-pocket costs required for life-sustaining medications," said Lyn Boocock-Taylor, chair of the PAN Board of Directors. "The needs of our patients and of the estimated 25 million underinsured people nationwide simply must be considered in the current health care reform debate."

For a number of patients struggling to meet medical costs, timely PAN help sometimes means the difference between life and death, as a cutaneous T-cell lymphoma patient from Colorado wrote: "I was dying because I did not have the means to fight my cancer...thanks, thanks, thanks."

For others, like a rheumatoid arthritis patient from Texas, PAN's assistance eliminated their need to make tough financial choices, saying that: "[With PAN help] I do not have to choose my treatment over other bills that need to be paid."

Patients receiving PAN assistance also reported a striking 28 percent increase (from 71 to 99 percent) in their ability to comply with physicians' medication orders, because of their copayment assistance for vital medications and infusions. Failure to take prescriptions as prescribed often disrupts the medication's helpful effects and can lead to negative consequences such as hospitalization.

Patients said that the copayment assistance reduced family financial and emotional strain, improved their overall health and ability to take medications as prescribed and sometimes sufficiently improved their health allowing their return to work or education.

"We know patients are struggling, but these survey results confirm that we are truly reaching those who need help and making a difference in their lives," said Julie Reynes, President of PAN.

Additionally, PAN enjoys a patient satisfaction rate of 97%. Patients say that PAN's professional case managers staffing the call center are compassionate and helpful.

A summary and more information are on the PAN Web site: www.patientaccessnetwork.org and a webcast featuring the survey is available at: https://patientaccessnetwork.webex.com/patientaccessnetwork/lsr.php?AT=pb&SP=EC&rID=1341952&rKey=59830011FFBA7F58.

PAN is a nonprofit foundation dedicated to providing copayment assistance to insured patients who otherwise lack the means to meet out-of-pocket medication costs for specific diseases. Since 2004, PAN has helped more than 60,000 patients across the United States and U.S. territories. It can be reached through the Web or toll-free at 866-316-7263, with Spanish available.


'/>"/>
SOURCE Patient Access Network Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
2. TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients
3. Physiological response may explain why some severely obese patients overeat
4. Kidney Community Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients in Iowa
5. In Some Insomnia Patients, Brain Just Wont Shut Down
6. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
7. PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients
8. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
9. Anesthesia Can Make Patients Vomit After Cosmetic Surgery - World's Top Expert Says PK Anesthesia Is Better
10. Kidney Community Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients in Washington, D.C.
11. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic brain ... conduct a survey that takes a closer look at cases of TBI being managed ... causes of TBI among the aging population, and identifies the challenges associated with their ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... announced that it has been awarded the prestigious Distinguished Emerald Club of the ... program conducted by BoardRoom magazine, one of the most respected trade publications serving ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics, who is celebrating ... evolved from humble beginnings to being an internationally recognized leader in their industry. , ... today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the importance of good ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and SAN DIEGO , ... Inc., a global leader in viral gene therapy manufacturing, ... treatments for congestive heart failure and other chronic diseases, ... a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) ... --> --> ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: